Lenvatinib and Everolimus in Treating Patients With Advanced, Unresectable Carcinoid Tumors
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Hoffmann-La Roche
Olivia Newton-John Cancer Research Institute
Jonsson Comprehensive Cancer Center
Imperial College London
Advanced Accelerator Applications
National Cancer Institute (NCI)
Ohio State University Comprehensive Cancer Center
University of Iowa
University Health Network, Toronto
University of Alberta
University of Iowa
Crinetics Pharmaceuticals Inc.
Amgen
Advanced Accelerator Applications
Merck Sharp & Dohme LLC
ITM Solucin GmbH
Sinotau Pharmaceutical Group
University of California, San Francisco
University of Iowa
British Columbia Cancer Agency
Orano Med LLC
ITM Solucin GmbH
Instituto do Cancer do Estado de São Paulo
Abramson Cancer Center at Penn Medicine
Memorial Sloan Kettering Cancer Center
Harbour BioMed (Guangzhou) Co. Ltd.
Melanoma and Skin Cancer Trials Limited
University Health Network, Toronto